Sudden idiopathic hearing loss

H8_HL_IDIOP

sensorineural hearing loss: Hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.2 Hospital discharge: ICD-9 — 3882 Cause of death: ICD-10 — H91.2 Cause of death: ICD-9 — 3882 2 out of 7 registries used, show all original rules.	3991
4. Check minimum number of events None	3991
5. Include endpoints None	3991
6. Filter based on genotype QC (FinnGen only)	3991

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H91
Name in latin: Hypacusis acuta idiopathica

NAME	H8_HL_IDIOP
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H912
HD_ICD_9	3882
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H912
COD_ICD_9	3882
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sudden idiopathic hearing loss based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	24447	12128	12214
Only index persons	23111	11603	11508
Unadjusted period prevalence (%)
Whole population	0.34	0.35	0.34
Only index persons	0.43	0.43	0.44
Median age at first event (years)
Whole population	58.15	58.52	57.78
Only index persons	57.56	57.96	57.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3991	2079	1912
Unadjusted period prevalence (%)	0.77	0.71	0.84
Median age at first event (years)	58.18	56.08	60.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3620: Matched controls
36198

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z01.1

ICD-10 Finland

Examination of ears and hearing

12.7

323.0

1172

1317

N07CA01

ATC

betahistine; oral

18.8

323.0

1215

948

DFF00

NOMESCO Finland

Pure tone audiometry

28.6

323.0

1028

494

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

343.1

323.0

648

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

113.3

323.0

1128

144

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

16384.0

323.0

3418

UDC00

NOMESCO Finland

Ear microscopy

10.9

300.4

612

663

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

252.0

239

H02AB06

ATC

prednisolone; systemic

3.3

250.2

2262

12110

H81.0

ICD-10 Finland

Ménière disease

24.3

237.3

344

156

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

91.5

237.0

263

H93.1

ICD-10 Finland

Tinnitus

14.4

234.7

413

321

H91.9

ICD-10 Finland

Hearing loss, unspecified

17.6

234.5

380

240

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

17.6

229.8

372

234

DFF15

NOMESCO Finland

Speech audiometry

20.5

223.6

342

183

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

58.7

221.7

262

H02

ICPC

Hearing complaint

5.5

210.9

696

1499

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

104.1

180.1

197

DAX08

NOMESCO Finland

Fitting of hearing aid

27.3

160.6

224

Z97.4

ICD-10 Finland

Presence of external hearing-aid

19.0

144.7

226

126

SPAT1043

SPAT

Audiometry

4.7

134.5

505

1212

R42

ICD-10 Finland

Dizziness and giddiness

2.8

128.1

1021

4437

H02AB04

ATC

methylprednisolone; systemic

2.8

96.3

708

2858

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

86.6

90.5

101

DFF59

NOMESCO Finland

Other assessment of balance

21.2

90.1

135

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

217.4

82.7

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

13.3

81.6

146

114

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

255.2

73.6

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

13.5

66.7

118

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

12.6

63.0

115

H81.3

ICD-10 Finland

Other peripheral vertigo

5.6

60.1

182

336

DC1AD

NOMESCO Finland

Temporalbone CT

21.2

57.1

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

24.0

55.9

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

52.0

336

1216

R5120

NOMESCO Finland

Preparation of an aid

8.1

51.6

119

151

H29

ICPC

Ear symptom/complaint other

2.6

50.9

410

1698

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

49.1

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

57.8

48.5

D33.30

ICD-10 Finland

Acoustic neuroma

24.7

48.1

H91.8

ICD-10 Finland

Other specified hearing loss

15.3

46.8

H91.1

ICD-10 Finland

Presbycusis

5.0

46.6

157

328

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

44.1

1578

11524

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

43.1

314

1223

A02BC02

ATC

pantoprazole; systemic

1.6

42.7

2266

18317

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.5

41.8

155

358

AA1AD

NOMESCO Finland

CT of head and brain

1.8

40.6

870

5430

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.4

40.5

370

1630

R4135

NOMESCO Finland

Rehabilitation for hearing problems

26.6

39.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

36.0

407

1984

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

35.5

670

3987

H92.0

ICD-10 Finland

Otalgia

3.5

34.0

166

491

R01AD09

ATC

mometasone; nasal

1.6

33.6

1428

10654

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

32.6

313

1411

H13

ICPC

Plugged feeling ear

1.8

32.2

612

3636

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

53.3

31.3

N02BE01

ATC

paracetamol; systemic, rectal

1.7

31.3

2976

26611

H28

ICPC

Limited function/disability (H)

9.7

30.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

30.8

1628

12687

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

30.8

733

4667

A02BC03

ATC

lansoprazole; oral

1.6

28.8

997

7009

J01FA10

ATC

azithromycin; systemic

1.5

28.2

1805

14546

J01CA04

ATC

amoxicillin; systemic

1.5

28.1

2658

23286

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

100.8

27.7

SPAT1263

SPAT

Sampling

1.5

27.6

1388

10611

R01AD12

ATC

fluticasone furoate; nasal

1.6

26.7

849

5821

R51.80

ICD-10 Finland

Headache

1.9

26.5

447

2536

A02BC05

ATC

esomeprazole; systemic

1.5

26.4

1346

10293

SPAT1153

SPAT

Removal of sutures

1.5

26.4

1090

7957

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

26.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

25.9

1495

11719

R01AD08

ATC

fluticasone; nasal

1.6

25.6

885

6186

H81.2

ICD-10 Finland

Vestibular neuronitis

4.1

25.3

101

252

TDA90

NOMESCO Finland

Removal wax from ear

7.1

25.3

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

50.4

25.2

J01AA02

ATC

doxycycline; systemic

1.5

25.2

2639

23265

M03BX02

ATC

tizanidine; oral

1.4

25.0

1974

16426

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

24.9

955

6833

M01AH05

ATC

etoricoxib; oral

1.4

24.9

1903

15727

SPAT1312

SPAT

General health counselling

1.5

24.8

1002

7259

J01DB01

ATC

cefalexin; oral

1.5

24.5

2749

24497

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

24.1

115

335

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

24.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

23.7

1084

8050

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

3.9

23.7

258

SPAT1310

SPAT

Counselling related to known health issue

1.5

23.3

1029

7581

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.2

23.3

219

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

22.7

334

1801

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

22.0

721

4948

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

21.7

1360

10716

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

21.5

535

3412

G44.2

ICD-10 Finland

Tension-type headache

1.8

21.4

391

2274

A98

ICPC

Health maint/preventive medicine

1.8

21.1

3348

31590

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

20.2

740

5203

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

20.1

397

2363

H93.2

ICD-10 Finland

Other abnormal auditory perceptions

9.8

20.0

M01AE02

ATC

naproxen; oral, rectal

1.4

19.9

1760

14681

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

19.8

555

3653

N17

ICPC

Vertigo/dizziness

1.8

19.7

349

2008

H61.2

ICD-10 Finland

Impacted cerumen

2.3

19.2

189

858

M25.5

ICD-10 Finland

Pain in joint

1.5

19.0

847

6201

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

18.9

863

6349

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

18.8

1146

8919

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

18.8

921

6875

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.4

18.3

161

693

N06AX11

ATC

mirtazapine; oral

1.4

18.2

968

7338

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

17.9

1148

8997

N02AX02

ATC

tramadol; systemic, rectal

1.4

17.5

1361

11021

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

17.5

299

1698

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

17.1

1246

9968

R03AC02

ATC

salbutamol; inhalant

1.4

17.1

1592

13266

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

16.9

921

6996

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

16.6

749

5476

S18

ICPC

Laceration/cut

1.4

16.6

1354

11023

N03AX12

ATC

gabapentin; oral

1.6

16.5

475

3137

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

16.4

2169

19041

SPAT1041

SPAT

Comprehensive hearing test

5.4

16.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

16.3

1268

10235

DFF50

NOMESCO Finland

Electronystagmography

21.0

16.0

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

15.8

153

691

SPAT1301

SPAT

No procedures

1.4

15.8

982

7621

H83.1

ICD-10 Finland

Labyrinthine fistula

60.2

15.8

Z45.3

ICD-10 Finland

Adjustment and management of implanted hearing device

+∞

15.6

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

15.5

585

4115

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

15.0

1671

14200

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

15.0

305

1827

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

14.8

569

4016

H25.8

ICD-10 Finland

Other senile cataract

1.7

14.6

338

2106

R06.0

ICD-10 Finland

Dyspnoea

1.4

14.6

761

5708

M54.5

ICD-10 Finland

Low back pain

1.4

14.5

956

7476

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

14.4

320

1969

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

14.4

237

1330

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

14.2

242

1370

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

14.1

505

3507

UKC02

NOMESCO Finland

Cystoscopy

1.5

14.1

516

3600

M79.1

ICD-10 Finland

Myalgia

1.6

14.0

362

2323

H80.9

ICD-10 Finland

Otosclerosis, unspecified

6.7

14.0

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

13.9

722

5404

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

13.8

337

2129

M79.6

ICD-10 Finland

Pain in limb

1.4

13.8

1060

8487

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

13.7

273

1625

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

75.4

13.6

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

3.8

13.5

148

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

13.5

538

3819

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

13.4

199

1076

R01AD01

ATC

beclometasone; nasal

1.5

13.2

439

2993

M02AA07

ATC

piroxicam; topical

1.3

13.2

1130

9183

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

13.2

290

1778

N03AX16

ATC

pregabalin; oral

1.4

13.2

710

5344

H01

ICPC

Ear pain/earache

1.7

13.1

276

1669

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

15.1

13.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

13.1

545

3904

N05CF01

ATC

zopiclone; oral

1.3

13.0

1001

7998

A02BC01

ATC

omeprazole; systemic

1.4

13.0

837

6498

H66.9

ICD-10 Finland

Otitis media, unspecified

2.2

13.0

132

615

A02BC04

ATC

rabeprazole; oral

1.8

12.9

238

1382

SPAT1260

SPAT

Consultation of another employee

1.5

12.9

532

3805

DE2CF

NOMESCO Finland

Acoustic channel extensive MRI examination with median intensity magnet

50.2

12.8

R74

ICPC

Upper respiratory infection acute

1.4

12.7

722

5484

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

5.4

12.7

H83.3

ICD-10 Finland

Noise effects on inner ear

5.8

12.7

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

6.4

12.6

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

12.5

UJF32

NOMESCO Finland

Coloscopy

1.4

12.5

792

6127

H03

ICPC

Tinnitus, ringing/buzzing ear

3.3

12.5

191

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

12.4

162

838

J01FF01

ATC

clindamycin; systemic

1.4

12.3

801

6222

SPAT1325

SPAT

Vaccination

1.3

12.3

1056

8571

SPAT1216

SPAT

Assessment of functional ability

1.5

12.1

467

3288

SPAT1097

SPAT

Recording of ECG

1.5

12.1

455

3188

XKD00

NOMESCO Finland

Uroflowmetry

1.5

12.1

504

3607

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

18.1

12.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

12.0

983

7915

H60.3

ICD-10 Finland

Other infective otitis externa

2.9

11.9

248

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.9

407

2791

J01FA09

ATC

clarithromycin; systemic

1.3

11.9

909

7238

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

11.9

658

4968

J05AB01

ATC

aciclovir; systemic

1.4

11.8

600

4458

D82

ICPC

Teeth/gum disease

1.3

11.8

942

7549

J01DA01

ATC

[U] cefalexin; systemic

1.3

11.8

1955

17311

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.7

1001

8105

R06AE07

ATC

cetirizine; oral

1.3

11.6

1246

10410

Z97.8

ICD-10 Finland

Presence of other specified devices

16.4

11.6

R05

ICPC

Cough

1.4

11.6

633

4761

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.6

906

7235

H84

ICPC

Presbyacusis

2.7

11.5

305

G47.3

ICD-10 Finland

Sleep apnoea

1.4

11.5

608

4552

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

11.5

DC1AI

NOMESCO Finland

Cone beam CT of ear

120.3

11.4

L01

ICPC

Neck symptom/complaint

1.5

11.4

363

2451

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

11.4

203

1171

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

11.3

2944

27625

K08.80

ICD-10 Finland

Toothache NOS

1.8

11.3

202

1166

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

11.2

407

2828

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

11.1

181

1014

L17

ICPC

Foot/toe symptom/complaint

1.4

11.1

751

5860

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

11.0

191

1090

M01AB05

ATC

diclofenac; systemic, rectal

1.3

11.0

2086

18706

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

11.0

390

2695

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

11.0

682

5245

J02AC01

ATC

fluconazole; systemic

1.3

10.8

1095

9059

R05

ICD-10 Finland

Cough

1.4

10.8

541

4009

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

10.8

168

926

DDA00

NOMESCO Finland

Stapedotomy

7.2

10.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

10.7

243

1505

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

10.7

244

1515

A06AC51

ATC

ispaghula, combinations; systemic

1.9

10.6

148

786

C10AA07

ATC

rosuvastatin; oral

1.3

10.5

751

5901

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.5

698

5423

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

10.5

175

987

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

10.5

381

2651

C07AB07

ATC

bisoprolol; oral

1.3

10.4

1515

13115

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

10.4

135

697

L08

ICPC

Shoulder symptom/complaint

1.4

10.3

552

4131

L03

ICPC

Low back symptom/complaint

1.4

10.3

685

5320

A02BA02

ATC

ranitidine; systemic

1.4

10.3

585

4423

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

10.3

253

1602

H71

ICD-10 Finland

Cholesteatoma of middle ear

5.1

10.3

N05BA04

ATC

oxazepam; oral

1.3

10.3

707

5520

R06AX27

ATC

desloratadine; oral

1.4

10.3

686

5332

K07.60

ICD-10 Finland

Snapping jaw

2.0

10.2

119

591

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

10.2

629

4829

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

10.1

437

3143

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

10.1

407

2889

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

10.1

209

1264

SPAT1211

SPAT

Application of soft bandage

1.6

10.1

262

1683

J05AB11

ATC

valaciclovir; oral

1.5

10.1

372

2592

SPAT1044

SPAT

Tympanometry

2.8

10.0

229

Z01.2

ICD-10 Finland

Dental examination

1.3

10.0

1136

9524

C01CA24

ATC

epinephrine; parenteral

1.9

10.0

152

833

N05AB04

ATC

prochlorperazine; systemic, rectal

2.5

10.0

303

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

10.0

282

1851

WX110

NOMESCO Finland

Local anesthesy

1.3

9.9

2118

19149

E0000UV

ATC

1.3

9.9

1142

9586

H02AB07

ATC

prednisone; oral

1.4

9.9

419

3004

D07AC13

ATC

mometasone; topical

1.3

9.7

842

6802

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

9.7

121

615

XQ800

NOMESCO Finland

Prick test

1.7

9.6

184

1085

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

9.6

155

865

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

9.6

437

X58

ICD-10 Finland

Exposure to other specified factors

1.5

9.6

369

2593

G04CA02

ATC

tamsulosin; oral

1.3

9.6

685

5375

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.6

2101

19016

H91

ICD-10 Finland

Other hearing loss

5.0

9.5

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

9.5

169

977

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

9.4

323

2216

R21

ICPC

Throat symptom/complaint

1.4

9.4

462

3404

DCA30

NOMESCO Finland

Exploration of middle ear

30.1

9.4

XA410

NOMESCO Finland

BAEP

+∞

9.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

9.4

1663

14678

J01MA02

ATC

ciprofloxacin; systemic

1.3

9.3

1182

10032

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.2

332

2299

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

9.2

120

622

H26.4

ICD-10 Finland

After-cataract

1.6

9.2

251

1630

R13

ICD-10 Finland

Dysphagia

1.7

9.2

180

1071

N01

ICPC

Headache

1.6

9.2

226

1434

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

9.1

1375

11895

J01MA01

ATC

ofloxacin; systemic

1.6

9.1

255

1670

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

9.1

757

6069

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

9.1

432

3164

H65.0

ICD-10 Finland

Acute serous otitis media

3.5

9.1

114

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

9.1

220

1391

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

9.1

456

3374

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

9.0

232

1487

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

8.9

1015

8489

SPAT1053

SPAT

Memory test

1.4

8.9

431

3172

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

8.8

265

1763

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.9

8.8

183

R07.0

ICD-10 Finland

Pain in throat

1.8

8.7

149

850

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

8.7

205

1285

C05AA08

ATC

fluocortolone; rectal, topical

1.4

8.7

401

2922

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

8.7

139

777

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

8.6

1269

10933

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

8.6

146

832

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.6

1254

10792

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

8.6

691

5514

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

8.5

1855

16673

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

8.5

1188

10172

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

8.4

508

3876

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

8.4

431

3202

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.4

8.4

117

B01AA03

ATC

warfarin; systemic

1.3

8.4

601

4713

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

8.4

242

1599

DFD20

NOMESCO Finland

Closure of rupture of round window

+∞

8.3

3897A

ICD-9 Finland

Deafness, Deaf mutism, not elsewhere classifiable[SURDITAS]

+∞

8.3

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

3.3

8.3

123

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.3

389

2841

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

8.3

728

5872

H01.0

ICD-10 Finland

Blepharitis

1.8

8.3

136

768

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

8.3

176

1072

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

8.2

1020

8599

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

8.2

322

2273

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

14.5

8.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.2

706

5682

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

8.1

363

2633

C08CA05

ATC

nifedipine; systemic

1.6

8.0

184

1147

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

8.0

1144

9798

B01AF01

ATC

rivaroxaban; oral

1.4

8.0

354

2554

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.6

8.0

219

L57.0

ICD-10 Finland

Actinic keratosis

1.5

8.0

287

1993

R04.0

ICD-10 Finland

Epistaxis

1.6

8.0

205

1315

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

7.9

161

969

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

7.9

505

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

7.9

186

1168

H81

ICPC

Excessive ear wax

1.4

7.9

437

3287

Z00.0

ICD-10 Finland

General medical examination

1.3

7.9

524

4060

ZXA10

NOMESCO Finland

Bilateral

1.3

7.9

526

4076

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

7.8

7.9

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.8

1143

9810

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

7.8

113

611

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

7.7

304

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.7

718

5833

C10AA05

ATC

atorvastatin; oral

1.2

7.7

1205

10414

R51

ICD-10 Finland

Headache

1.8

7.7

124

697

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.4

7.7

275

C09CA06

ATC

candesartan; oral

1.3

7.7

608

4830

WZA90

NOMESCO Finland

Other doctors statement

1.3

7.6

627

5008

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

7.6

764

6268

H60.8

ICD-10 Finland

Other otitis externa

2.2

7.6

311

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

7.5

149

892

M48.0

ICD-10 Finland

Spinal stenosis

1.4

7.5

353

2580

SPAT1058

SPAT

PEF monitoring instruction

1.5

7.5

228

1523

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

7.5

336

D06

ICPC

Abdominal pain localized other

1.6

7.5

202

1311

SPAT1104

SPAT

Monitoring of emergency patient

1.6

7.5

189

1207

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.4

757

6218

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

80.2

7.4

AAE32

NOMESCO Finland

Translabyrinthine excision acoustic neurinome

80.2

7.4

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.4

1609

14375

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.6

7.4

187

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

7.4

303

2158

A03FA02

ATC

cisapride; oral, rectal

1.5

7.4

223

1489

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

7.4

261

A03

ICPC

Fever

1.4

7.3

372

2758

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

7.3

131

763

DE2BM

NOMESCO Finland

Acoustic channel MRI examination with 3 Tesla magnet

+∞

7.3

38920

ICD-8 Finland

Other deafness, Deafness, one ear

+∞

7.3

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

7.3

1335

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.8

7.3

153

C10AA01

ATC

simvastatin; oral

1.2

7.3

1391

12261

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

7.3

247

1695

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

7.2

1515

13477

SPAT1254

SPAT

Administration of medicine

1.4

7.2

398

2994

K59.0

ICD-10 Finland

Constipation

1.7

7.2

147

890

M01AX05

ATC

glucosamine; oral

1.3

7.1

600

4808

J01MA12

ATC

levofloxacin; systemic

1.3

7.1

527

4147

TAB00

NOMESCO Finland

Lumbar puncture

1.8

7.1

109

605

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

7.1

640

5174

N03AX11

ATC

topiramate; oral

2.4

7.1

234

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

7.1

461

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.0

840

7028

L12

ICPC

Hand/finger symptom/complaint

1.4

7.0

365

2715

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

7.0

413

3140

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

7.0

447

3441

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

7.0

277

1962

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

7.0

115

651

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

6.9

208

1389

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

6.9

206

1374

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

6.9

248

1723

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

13.8

6.9

G35

ICD-10 Finland

Multiple sclerosis

2.7

6.9

171

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.1

6.9

326

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

6.8

105

584

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

6.8

332

2441

Z04.3

ICD-10 Finland

Examination and observation following other accident

2.2

6.8

286

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

10.9

6.8

M01AX17

ATC

nimesulide; oral

1.3

6.8

717

5912

R03BA05

ATC

fluticasone; inhalant

1.3

6.7

463

3602

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

6.7

170

1089

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

6.7

647

5275

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

6.7

681

5589

J02AC02

ATC

itraconazole; systemic

1.3

6.7

483

3785

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

6.7

1193

10423

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

6.6

239

1659

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.4

6.6

213

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

6.6

135

819

R03DC03

ATC

montelukast; oral

1.3

6.6

404

3086

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

5.9

6.6

DHB50

NOMESCO Finland

Turbinoplasty

2.1

6.6

306

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

6.5

473

3706

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

6.5

1864

17017

N06AB10

ATC

escitalopram; oral

1.3

6.4

474

3723

H91.0

ICD-10 Finland

Ototoxic hearing loss

69.9

6.4

L15

ICPC

Knee symptom/complaint

1.3

6.4

567

4567

M54.2

ICD-10 Finland

Cervicalgia

1.6

6.4

173

1126

XF402

NOMESCO Finland

ECG with work load test

1.4

6.4

317

2340

I73.0

ICD-10 Finland

Raynaud syndrome

2.6

6.4

160

R5599

NOMESCO Finland

Other rehabilitation service

2.1

6.4

342

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.4

1028

8874

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

6.4

146

914

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

6.3

764

6390

A01

ICPC

Pain general/multiple sites

1.5

6.3

198

1337

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

6.3

425

3295

H72.2

ICD-10 Finland

Other marginal perforations of tympanic membrane

8.1

6.3

R00.2

ICD-10 Finland

Palpitations

1.6

6.3

172

1123

J01DC02

ATC

cefuroxime; systemic

1.6

6.3

139

862

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

6.3

645

5292

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.3

424

3290

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

6.3

170

1112

DE2DM

NOMESCO Finland

Very extensive 3 T MRI of internal auditory canal

+∞

6.2

3883A

ICD-9 Finland

Other disorders of ear, Tinnitus

+∞

6.2

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

6.2

105

600

UDM02

NOMESCO Finland

Sinoscopy

2.1

6.2

305

R02

ICPC

Shortness of breath/dyspnoea

1.4

6.2

313

2318

R53

ICD-10 Finland

Malaise and fatigue

1.3

6.2

537

4309

FN1AD

NOMESCO Finland

CT of coronary arteries

2.5

6.2

175

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.2

1105

9636

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

5.0

6.2

J01EA01

ATC

trimethoprim; systemic

1.3

6.2

675

5586

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.1

301

2216

H69.0

ICD-10 Finland

Patulous Eustachian tube

5.7

6.1

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

6.1

148

938

R15

ICD-10 Finland

Faecal incontinence

2.0

6.1

348

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

6.1

487

R05FB02

ATC

cough suppressants and expectorants

1.2

6.0

1106

9664

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

6.0

270

1959

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

6.0

213

1478

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

576

1895

3.38

140.21

1.3

au/ml

24.9

51.2

2.66

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

610

2097

3.25

138.11

2.5

2.4

au/ml

31.0

21.9

0.50

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

845

3997

2.41

101.13

4.8

4.6

33.1

32.5

0.75

585

2617

(3013512) EKG study

1479

9657

1.84

70.04

4.5

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1770

12660

1.72

58.13

4.1

3.6

ng/l

51.0

84.8

0.43

1263

8975

(3019225) pH of Specimen

637

3331

2.09

56.67

3.7

4.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2868

24141

1.67

44.19

4.9

4.1

mm/h

12.1

13.0

2.36

2605

22239

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3346

29592

1.81

40.62

5.3

4.7

mu/l

1.9

2.1

1.43

2998

26932

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3585

32513

2.01

38.78

17.2

15.0

mg/l

21.5

25.0

7.93

2886

25999

(3023103) Potassium [Moles/volume] in Serum or Plasma

3696

33986

2.18

37.06

20.0

17.5

mmol/l

4.0

0.19

3588

33102

(3019550) Sodium [Moles/volume] in Serum or Plasma

3684

33886

2.13

36.05

19.8

17.4

mmol/l

139.7

139.6

1.02

3586

33058

(3032080) INR in Blood by Coagulation assay

1788

13967

1.51

34.01

11.5

9.5

inr

1.3

0.66

501

3950

(40761511) CBC panel - Blood by Automated count

3657

33718

2.01

32.85

17.5

14.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2936

25661

1.55

30.88

8.6

7.8

u/l

77.3

79.1

1.19

2717

24193

(42870588) Differential panel, method unspecified - Blood

1470

11245

1.49

29.77

6.7

5.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1327

9956

1.50

29.51

3.3

3.0

ng/l

1754.0

1512.1

0.55

1101

8607

(3010813) Leukocytes [#/volume] in Blood

3817

36011

2.38

28.40

25.8

22.0

e9/l

6.8

0.01

3716

34915

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1350

10224

1.48

28.40

2.4

2.2

u/l

211.9

214.7

0.03

1238

9574

(3024731) MCV [Entitic volume]

3816

36000

2.37

28.36

25.7

21.9

91.2

91.3

0.65

3758

35468

(3007461) Platelets [#/volume] in Blood

3815

35987

2.36

28.35

25.8

22.0

e9/l

245.5

248.4

2.04

3725

35030

(3035941) MCH [Entitic mass]

3816

36001

2.37

28.34

25.6

21.9

30.4

0.21

3758

35468

(3026361) Erythrocytes [#/volume] in Blood

3816

36004

2.37

28.28

25.8

22.0

e12/l

4.5

0.06

3719

34903

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3474

31796

1.71

28.19

5.1

4.7

mmol/l

6.0

0.17

3075

28864

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2808

24489

1.49

28.19

4.4

3.9

pmol/l

15.0

14.9

3.17

2508

22178

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3715

34706

2.02

28.07

12.4

10.7

u/l

26.0

26.4

0.53

3524

33445

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1891

15304

1.45

28.06

6.6

6.1

mmol/l

1.2

2.68

1658

13871

(3000963) Hemoglobin [Mass/volume] in Blood

3816

36016

2.36

28.05

25.9

22.1

g/l

135.1

135.0

0.16

3756

35483

(3037467) Urinalysis macro (dipstick) panel - Urine

2614

22512

1.47

27.66

5.0

4.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1356

10345

1.47

27.20

2.8

2.6

u/l

55.8

57.9

1.29

1227

9543

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3472

31905

1.68

26.08

5.1

4.5

mmol/l

1.5

0.02

3108

29242

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

631

4116

1.63

25.69

7.3

6.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2323

19719

1.43

25.44

5.3

4.8

mmol/l

6.8

0.30

2177

18497

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3324

30286

1.58

25.08

6.5

5.9

mmol/mol

40.1

0.14

2988

27939

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3488

32157

1.67

25.05

5.1

4.5

mmol/l

4.6

3.19

3141

29647

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3370

30836

1.60

24.61

4.5

4.0

mmol/l

1.3

0.47

3003

28042

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

253

1269

2.06

24.41

3.9

4.0

mmol/l

25.2

24.9

0.76

237

1164

(3022313) Gas panel - Capillary blood

279

1488

1.94

22.62

3.8

3.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1644

13320

1.40

22.45

2.4

2.2

nmol/l

79.6

78.0

1.53

1437

11897

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3533

32851

1.66

22.42

5.5

5.0

mmol/l

2.7

3.16

3152

30125

(3019309) Folate [Moles/volume] in Red Blood Cells

872

6297

1.49

22.25

1.8

nmol/l

1157.3

1163.0

0.06

624

4736

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2414

20888

1.39

22.03

3.4

3.1

u/l

47.7

52.0

1.65

2185

19306

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2077

17536

1.38

21.95

6.4

umol/l

11.3

11.6

0.43

1940

16664

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3360

30919

1.55

21.78

15.4

14.2

ml/min/173m2

77.3

78.9

4.38

2837

25563

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

359

2101

1.78

21.67

3.8

3.7

kpa

5.1

5.2

0.21

329

1941

(3009343) pH of Capillary blood

354

2071

1.78

21.39

3.8

3.7

7.4

0.34

265

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2005

16875

1.38

21.36

7.6

6.9

mmol/l

1.2

1.14

1627

14231

(3031040) Bacteria [#/volume] in Urine by Automated count

2483

21652

1.39

21.20

5.2

4.5

e6/l

592.2

1181.0

0.58

315

(3013115) Eosinophils [#/volume] in Blood

2006

16910

1.37

21.03

6.6

6.0

e9/l

0.2

0.14

1774

14684

(3006504) Eosinophils/100 leukocytes in Blood

1842

15355

1.37

20.51

6.9

6.0

2.9

2.8

0.18

1698

14277

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

340

1997

1.77

20.24

3.7

3.6

mmol/l

2.0

1.9

0.25

262

1496

(3019069) Monocytes/100 leukocytes in Blood

1847

15430

1.37

20.16

7.3

6.3

8.6

8.7

0.67

1707

14402

(3022096) Basophils/100 leukocytes in Blood

1789

14917

1.36

19.55

6.9

6.1

0.7

1.72

1643

13882

(3002030) Lymphocytes/100 leukocytes in Blood

1879

15798

1.36

19.41

7.0

6.1

27.1

27.2

0.23

1717

14663

(3006315) Basophils [#/volume] in Blood

1937

16366

1.36

19.36

6.5

5.8

e9/l

0.0

0.00

1724

14004

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

104

395

2.68

19.06

2.1

mg/l

25.5

24.6

0.05

(3001604) Monocytes [#/volume] in Blood

1926

16289

1.35

18.98

6.5

5.8

e9/l

0.6

0.75

1717

13929

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1663

13793

1.35

18.44

2.1

2.0

pmol/l

96.8

94.3

1.20

862

7116

(3018010) Neutrophils/100 leukocytes in Blood

1848

15575

1.35

18.43

6.6

5.9

58.1

57.7

0.65

1699

14526

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

727

5263

1.47

17.86

1.3

iu/ml

36.0

34.6

0.08

215

1657

(3019198) Lymphocytes [#/volume] in Blood

1960

16734

1.34

17.60

6.6

5.9

e9/l

1.9

0.09

1756

14562

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1614

13399

1.34

17.49

3.3

2.8

ug/l

141.4

138.9

0.10

1456

12352

(3024561) Albumin [Mass/volume] in Serum or Plasma

1746

14671

1.34

17.41

5.2

5.0

g/l

35.6

35.1

3.21

1589

13617

(3037522) Nuclear Ab [Titer] in Serum

594

4156

1.50

17.25

1.4

1.3

titre

559.6

525.3

0.17

113

871

(3017732) Neutrophils [#/volume] in Blood

349

2163

1.67

17.05

2.9

3.1

e9/l

4.0

4.2

0.50

235

1675

(40768804) Tissue Pathology biopsy report

1600

13420

1.32

15.58

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

677

4954

1.44

15.52

1.3

1.2

u/ml

12.6

12.9

0.03

213

1880

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

229

1296

1.81

15.43

1.8

—

(40768797) Stomach Pathology biopsy report

634

4589

1.45

15.39

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

242

1401

1.77

15.11

1.9

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1063

8437

1.35

14.97

2.5

2.2

mg/l

3.1

3.0

1.34

899

7198

(3004616) Nuclear Ab [Presence] in Serum

374

2.49

14.76

1.6

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1380

11408

1.32

14.65

3.1

3.5

mmol/l

2.3

2.4

1.07

1119

9935

(3022145) Colonoscopy Study observation

510

3638

1.46

13.25

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

839

6527

1.36

13.20

1.3

1.2

u/ml

1.7

1.9

0.18

205

1712

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

899

7070

1.35

13.18

1.7

pmol/l

16620156.0

28540217.2

0.42

710

5869

(3013650) Neutrophils [#/volume] in Blood by Automated count

2150

19066

1.28

12.65

8.9

9.2

e9/l

4.1

4.2

0.37

1904

16525

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

127

641

2.01

12.15

1.4

1.2

—

252.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1086

8874

1.31

12.02

2.8

umol/l

1815.0

5441.8

4.95

919

7652

(3021960) Folate [Moles/volume] in Serum or Plasma

977

7874

1.32

11.94

1.6

1.5

nmol/l

21.1

20.4

0.75

784

6716

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

714

5506

1.36

11.74

2.0

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1009

8195

1.31

11.61

2.6

2.4

—

(3048689) Calprotectin [Mass/mass] in Stool

492

3571

1.43

11.58

2.4

2.2

ug/g

119.5

149.9

1.25

376

2813

(3044640) Blood type and Crossmatch panel - Blood

1271

10709

1.27

10.86

2.6

2.5

—

(3038026) Centromere Ab [Units/volume] in Serum

253

2.51

10.48

1.4

1.1

—

58.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2071

18514

1.25

10.46

2.8

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1771

15664

1.23

9.51

4.2

4.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

419

2.08

9.15

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

407

2.09

9.07

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

408

2.08

9.01

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

409

2.08

8.96

1.3

1.5

—

(40761535) Cells panel - Urine sediment

372

2688

1.42

8.93

3.6

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3105

29275

1.27

8.89

17.0

16.2

39.5

39.6

0.06

1962

20499

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

181

1124

1.64

8.83

1.9

1.6

titre

231.4

289.0

0.23

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

133

760

1.78

8.80

1.1

u/ml

3.1

6.1

—

(3045424) Erythrocytes [Presence] in Urine

103

543

1.92

8.80

1.5

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

394

2891

1.40

8.67

2.2

nmol/l

371.5

374.2

0.09

359

2649

(40760892) CBC W Ordered Manual Differential panel - Blood

854

7033

1.27

8.45

4.8

4.5

—

(3009508) Creatinine [Moles/volume] in Urine

1248

10735

1.24

8.42

3.4

3.2

mmol/l

7.7

7.5

0.86

989

8972

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1368

11887

1.23

8.38

5.7

5.0

ug/l

2.9

3.3

0.38

1218

10647

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

413

2.03

8.38

1.4

1.5

—

(36660697) Celiac disease serology panel - Serum

326

2330

1.43

8.32

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

415

2.02

8.27

1.3

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

118

667

1.79

8.13

4.5

3.8

58.4

57.7

0.25

118

667

(3022217) INR in Platelet poor plasma by Coagulation assay

590

4663

1.31

7.99

32.8

25.3

inr

1.3

1.4

0.31

679

(3012516) Albumin [Mass/volume] in Urine

1198

10306

1.23

7.99

3.4

3.3

mg/l

550.2

324.1

0.70

702

6568

(3003338) MCHC [Mass/volume]

2553

27297

0.82

7.92

21.6

19.3

g/l

332.4

332.1

0.57

2543

27083

(3022948) Iron [Moles/volume] in Serum or Plasma

661

5316

1.29

7.85

3.2

2.6

umol/l

13.2

12.8

0.80

597

4933

(4146454)

370

2.05

7.78

2.4

2.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

252

1747

1.47

7.56

2.6

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

392

2948

1.37

7.43

2.6

2.5

e9/l

68.7

69.6

0.19

316

2173

(3004789) Transferrin [Mass/volume] in Serum or Plasma

612

4920

1.29

7.25

3.3

2.6

g/l

2.3

0.29

553

4564

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

578

4619

1.29

7.17

3.4

2.7

23.1

22.4

0.52

472

3961

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

852

7136

1.25

7.16

1.9

1.7

mg/l

1.1

1.3

1.67

625

5504

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

124

739

1.70

7.14

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

147

2.60

6.94

6.3

13.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

330

2447

1.38

6.83

3.2

2.6

g/l

10.4

10.5

0.09

296

2223

(40761536) Microorganisms panel - Urine sediment

365

2756

1.36

6.74

4.9

4.0

—

(3029937) Albumin [Presence] in Urine by Test strip

993

8502

1.22

6.73

4.6

4.1

estimate

0.0

1.34

383

2888

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

344

2574

1.37

6.73

4.1

4.0

ng/l

102.2

92.4

0.59

289

2217

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

569

4578

1.28

6.68

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

508

4028

1.30

6.67

4.5

4.3

u/l

236.5

246.9

1.08

477

3799

(3007164) IgA [Mass/volume] in Serum or Plasma

703

5803

1.26

6.67

1.6

1.4

g/l

2.4

2.5

0.69

412

3485

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

170

1118

1.54

6.60

3.0

2.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1232

10816

1.20

6.40

4.4

4.0

mg/mmol

11.3

9.7

0.48

719

6859

(3007853) Bacteria identified in Skin by Aerobe culture

476

3764

1.30

6.38

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

384

2947

1.34

6.37

2.5

2.6

g/l

66.5

66.3

0.16

335

2687

(4010399)

310

2302

1.38

6.37

1.5

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

496

3949

1.29

6.31

2.4

2.5

1.8

0.16

418

3505

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

144

922

1.58

6.30

1.9

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.46

6.28

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

683

1.67

6.23

1.7

1.3

u/l

10.7

10.1

0.18

568

(3004588) Protein electrophoresis panel - Serum or Plasma

322

2425

1.36

6.06

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

974

8414

1.21

5.93

3.7

3.4

—

(3023368) Bacteria identified in Blood by Culture

1083

9450

1.20

5.93

4.7

4.4

—

(3000494) Fungus identified in Specimen by Culture

473

3775

1.29

5.90

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

139

897

1.57

5.90

2.0

1.6

g/l

0.2

0.80

132

848

(3024139) IgG subclass 3 [Mass/volume] in Serum

297

2.00

5.88

1.8

1.3

g/l

0.4

0.34

212

(3028192) IgG subclass 2 [Mass/volume] in Serum

297

2.00

5.88

1.8

1.3

g/l

3.0

0.03

209

(3027135) IgG subclass 1 [Mass/volume] in Serum

297

2.00

5.88

1.8

1.3

g/l

6.1

6.9

1.15

211

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

143

930

1.56

5.87

2.0

1.5

g/l

1.2

0.66

136

879

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

417

3278

1.30

5.84

2.5

2.2

g/l

0.2

0.21

385

3046

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1353

12058

1.18

5.81

4.3

3.9

—

(4015189)

3.01

5.79

1.7

2.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

651

1.66

5.78

1.4

1.2

—

9.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

343

2631

1.33

5.72

3.9

0.6

0.08

586

(3009261) Glucose [Presence] in Urine by Test strip

1756

16024

1.17

5.60

4.1

3.7

estimate

0.0

1.06

385

2904

(3021601) Nitrite [Presence] in Urine by Test strip

1734

15827

1.17

5.47

5.2

4.9

estimate

0.0

0.80

398

3004

(3017181) Myelocytes/100 leukocytes in Blood

370

2888

1.31

5.47

4.0

4.1

0.8

0.9

0.42

119

822

(3003458) Phosphate [Moles/volume] in Serum or Plasma

553

4541

1.25

5.45

7.3

6.1

mmol/l

1.1

1.0

0.43

506

4215

(40768443) Skin Pathology biopsy report

199

1411

1.43

5.38

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

633

1.64

5.38

1.4

1.2

u/ml

5.0

4.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1727

15799

1.16

5.20

4.0

3.7

estimate

0.0

0.00

390

2958

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

175

1220

1.45

5.19

2.1

2.3

ug/l

380.6

540.5

0.64

159

1150

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

121

783

1.56

5.13

1.3

1.2

u/ml

7.1

0.00

114

(3025941) Bacteria identified in Stool by Culture

235

1732

1.38

5.10

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

192

1367

1.42

5.10

2.0

1.9

u/l

40.5

39.0

0.48

162

1198

(3017446) Testosterone [Moles/volume] in Serum or Plasma

313

2413

1.32

5.07

2.4

2.1

nmol/l

12.8

12.5

0.24

266

2121

(3014148) Varicella zoster virus Ab [Titer] in Serum

315

1.89

5.02

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

252

1885

1.36

5.00

3.3

pmol/l

4.3

4.4

1.29

215

1658

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

127

837

1.53

4.97

1.3

1.2

u/ml

22.4

45.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

641

5400

1.22

4.97

2.2

2.1

29.8

29.9

0.22

620

5245

(3020779) Urea [Moles/volume] in Serum or Plasma

401

3204

1.28

4.97

9.5

7.4

mmol/l

10.6

10.2

0.47

365

3053

(3049717) Cytology report of Urine Cyto stain

194

1391

1.41

4.96

2.6

2.7

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.67

4.92

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

330

2574

1.31

4.92

4.2

4.1

0.0

0.2

0.85

631

(4062490)

296

1.90

4.91

1.9

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

140

948

1.49

4.84

1.8

1.6

iu/ml

0.5

10.1

0.79

197

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

137

2.35

4.82

1.1

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

398

1.75

4.60

1.6

1.5

61.9

59.1

0.25

250

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

379

3038

1.27

4.58

2.4

2.3

ug/l

6.7

7.6

0.44

308

2678

(3032057) Clostridioides difficile [Presence] in Stool

2.81

4.54

1.7

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

276

1.90

4.54

2.1

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

143

987

1.47

4.52

1.5

1.4

ug/g

278.3

268.2

0.25

592

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

117

775

1.53

4.51

1.4

1.2

u/ml

12.3

3.6

0.40

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

195

1426

1.39

4.48

2.2

1.9

ug/l

1.2

2.6

1.94

157

1264

(3021440) Promyelocytes/100 leukocytes in Blood

345

2745

1.28

4.44

4.1

0.1

0.13

109

767

(3008757) Leukocyte morphology finding [Identifier] in Blood

351

1.78

4.42

4.7

4.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

313

2462

1.29

4.40

1.6

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

241

1828

1.34

4.39

1.3

u/ml

139.5

220.0

1.67

220

1667

(3036670) Protein [Mass/volume] in Synovial fluid

101

2.48

4.29

1.4

1.2

g/l

45.0

38.3

1.35

(1616796) Gas panel - Central venous blood

114

764

1.51

4.19

4.5

3.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

159

1137

1.41

4.18

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

350

1.75

4.18

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

158

1129

1.42

4.17

3.0

3.4

mg/l

34.8

56.3

1.03

130

923

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

113

757

1.51

4.16

1.4

1.3

—

(3014271) Vancomycin [Susceptibility]

173

2.09

4.16

2.9

3.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

158

1132

1.41

4.12

3.0

3.4

mg/l

43.7

107.1

0.69

129

926

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

208

1.98

4.11

2.8

2.4

e6/l

440.4

486.6

0.41

174

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

341

1.74

3.96

1.6

1.4

u/l

22.7

27.9

0.53

283

(3012501) Base excess in Blood by calculation

112

759

1.49

3.92

4.7

4.5

mmol/l

2.7

0.06

537

(3026389) Candida sp identified in Specimen by Organism specific culture

395

1.68

3.91

1.7

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

246

1908

1.31

3.87

2.2

1.8

g/l

1.4

0.02

217

1721

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

213

1.93

3.86

1.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

152

1096

1.40

3.84

3.0

3.3

ratio

3.4

2.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

133

937

1.43

3.83

1.8

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

117

805

1.47

3.81

1.5

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.54

3.79

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.54

3.79

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.54

3.79

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.54

3.79

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

252

1967

1.30

3.79

1.6

1.5

—

(3037121) Protein [Mass/volume] in Urine

156

1133

1.39

3.78

2.8

3.2

g/l

0.5

0.3

0.69

473

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

121

840

1.45

3.77

2.2

2.0

mg/l

10.4

11.5

1.17

113

783

(3010421) pH of Blood

128

902

1.43

3.69

4.6

4.4

7.4

0.06

110

748

(3016018) Differential panel - Cerebral spinal fluid

334

1.72

3.67

1.7

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

592

1.53

3.65

1.9

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

225

1.88

3.63

1.0

1.1

mg/l

34.3

45.1

1.03

184

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

432

3610

1.22

3.63

4.0

3.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

569

1.54

3.63

3.9

3.6

1.6

1.5

0.08

429

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

218

1.89

3.62

1.0

mg/l

251.1

300.5

0.91

186

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

131

932

1.42

3.59

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

113

783

1.46

3.57

1.8

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1061

9575

1.15

3.54

4.5

4.3

22.3

22.0

0.26

528

4806

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

327

2662

1.25

3.51

2.9

2.7

ml/min/173m2

56.8

64.8

3.18

136

1062

(3026008) Bacteria identified in Urine by Culture

1116

10119

1.14

3.47

3.4

3.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

210

1623

1.31

3.43

1.7

g/l

1.5

1.6

0.07

180

1399

(3012095) Magnesium [Moles/volume] in Serum or Plasma

653

5697

1.17

3.42

3.6

3.3

mmol/l

0.8

0.37

600

5318

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

114

800

1.44

3.39

1.8

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

262

2091

1.27

3.35

1.7

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.25

3.34

1.3

1.2

mmol/l

6.3

5.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.25

3.34

3.4

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

189

1.91

3.33

1.1

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

395

3301

1.22

3.33

1.7

1.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

123

879

1.41

3.32

2.9

3.2

mmol/l

25.3

25.2

0.10

107

764

(3015171) Extractable nuclear Ab [Units/volume] in Serum

155

1153

1.36

3.29

1.2

u/ml

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

190

1.90

3.28

1.1

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

101

698

1.46

3.27

3.3

3.1

nmol/l

0.7

0.8

1.58

535

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

346

1.66

3.26

1.1

—

4.5

—

(40768793) Breast Pathology biopsy report

104

724

1.45

3.24

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

652

1.47

3.19

1.5

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

530

1.52

3.19

2.5

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

729

1.44

3.14

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.25

3.12

1.1

1.3

ug/l

20.7

449.0

—

(3045414) Leukocytes [Presence] in Urine

191

1480

1.31

3.09

1.9

—

(3008898) HLA-B27 [Presence]

127

926

1.38

3.08

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

7.51

3.05

1.2

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

118

851

1.40

3.05

3.5

3.0

mg/l

1.7

1.6

0.67

106

778

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

133

981

1.37

3.01

1.8

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

339

1.63

3.00

4.0

3.7

60.1

57.8

0.31

206

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.24

2.96

3.8

2.6

—

(3048879) Bone marrow aspiration report

2.24

2.96

1.5

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

134

993

1.36

2.95

1.9

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

102

722

1.42

2.94

3.2

2.4

16.0

0.01

380

(3002256) Pathology report gross observation

512

4439

1.18

2.90

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

261

2121

1.25

2.89

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

214

1.78

2.87

2.3

1.8

nmol/l

18.4

17.0

0.35

200

(3021879) Hepatitis B virus core Ab [Presence] in Serum

262

2134

1.24

2.85

1.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

116

845

1.38

2.85

2.0

1.8

nmol/l

42.2

41.3

0.17

109

812

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

445

3819

1.19

2.84

1.8

1.7

—

(3011412) CD3 cells [#/volume] in Blood

306

1.64

2.82

2.8

2.3

e9/l

0.9

1.1

1.30

186

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

216

1.77

2.79

2.8

2.3

e6/l

613.3

614.6

0.01

(3042936) Bacteria identified in Isolate by Culture

541

4729

1.17

2.77

2.4

2.0

—

(3044927) Protein electrophoresis panel - Urine

332

1.60

2.74

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

5.01

2.72

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

4.22

2.67

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

771

1.39

2.65

2.5

2.2

g/l

129.3

128.3

0.17

551

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.13

2.64

1.4

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

596

1.44

2.62

1.7

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

589

1.44

2.59

5.8

3.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

385

1.54

2.58

4.9

6.3

mmol/l

7.7

7.5

0.14

322

(21494815) CD4 cells/100 lymphocytes in Specimen

260

1.66

2.57

2.0

2.1

38.5

40.9

0.14

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

475

1.48

2.56

1.8

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

113

837

1.36

2.54

3.4

3.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

492

1.47

2.54

2.0

1.6

g/l

0.8

0.10

380

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

650

1.41

2.54

2.1

u/l

1299.3

4840.6

1.55

270

(3000850) Epithelial cells [#/volume] in Urine

799

7230

1.13

2.49

3.1

2.6

e6/l

4.2

5.5

2.94

705

6321

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

462

1.48

2.48

1.8

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

3.47

2.48

1.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

116

1.99

2.45

1.0

1.1

u/ml

3.7

0.4

—

(3019060) Gas panel - Arterial blood

279

2329

1.21

2.44

5.4

4.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.95

2.41

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

112

837

1.35

2.40

1.7

1.6

e6/l

13082.3

12714.6

0.04

596

(3019174) dRVVT (LA screen)

3.34

2.39

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

102

752

1.37

2.38

3.0

kpa

8.1

8.0

0.32

695

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.75

2.37

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.26

2.37

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

6.26

2.37

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

243

1.65

2.37

1.7

1.5

u/ml

22.9

20.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

298

1.58

2.35

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

527

1.43

2.32

1.7

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

396

3430

1.17

2.30

1.6

—

(3026782) Osmolality of Urine

744

6736

1.13

2.30

3.5

2.7

mosm/kgh2o

547.7

550.0

0.10

639

5731

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.12

2.28

1.8

1.6

ug/l

0.5

0.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1384

1.26

2.26

2.1

2.2

g/l

7.3

7.4

0.56

123

1066

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

1304

1.27

2.26

2.1

2.3

g/l

3.0

3.1

0.54

115

1044

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

382

1.50

2.25

1.3

nmol/l

—

(1761868) Lipid panel - Serum or Plasma

1173

10907

1.11

2.24

3.0

2.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

334

1.53

2.24

2.3

2.9

—

(3047181) Lactate [Moles/volume] in Blood

137

1066

1.30

2.24

6.4

6.6

mmol/l

1.3

0.21

125

935

(3020961) Endomysium IgA Ab [Titer] in Serum

166

1324

1.26

2.23

1.1

titre

340.0

239.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

474

1.44

2.21

6.5

6.6

mg/l

12.0

0.00

435

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

335

1.53

2.21

1.5

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

376

1.50

2.20

1.9

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

150

1.81

2.19

2.4

3.3

mu/l

19.4

25.6

0.68

145

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

957

8813

1.11

2.19

1.7

1.6

mmol/l

1.3

1.4

0.49

796

7386

(3039000) Anion gap in Blood

104

781

1.34

2.19

7.0

7.5

mmol/l

11.2

0.10

689

(3018572) Chloride [Moles/volume] in Blood

104

781

1.34

2.19

7.0

7.5

mmol/l

103.8

105.2

1.67

689

(3010838) Calcium [Moles/time] in 24 hour Urine

165

1.76

2.18

1.6

—

9.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

273

1.58

2.17

3.9

4.9

u/ml

48.8

67.6

0.33

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

1.87

2.16

1.2

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

159

1.77

2.13

1.7

2.4

92.5

97.1

0.33

151

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

447

3934

1.15

2.12

1.7

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

1298

1.26

2.11

2.1

2.2

g/l

9.9

10.3

0.71

121

1109

(3042631) Mycobacterium sp identified in Specimen

472

1.43

2.08

2.8

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1382

1.25

2.07

2.1

2.2

g/l

3.8

0.07

113

1024

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1382

1.25

2.07

2.1

2.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

238

1.60

2.04

1.4

1.8

umol/l

18.1

6.3

0.60

167

(3005570) Glucose [Moles/volume] in Urine

310

1.52

2.03

1.5

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

765

6994

1.12

2.00

3.2

3.1

ug/l

0.8

0.17

519

4802

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

1.71

2.00

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

336

1.49

1.98

1.6

1.5

nmol/l

0.2

0.3

1.02

253

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

361

1.47

1.97

1.5

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

217

1.62

1.96

1.2

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.74

1.96

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

112

1.88

1.96

2.1

2.5

umol/l

24.9

29.2

1.10

(40765096) Chromosome analysis panel by Banding

105

1.91

1.95

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

297

1.52

1.95

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.36

1.94

1.0

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

273

1.54

1.94

1.9

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

118

920

1.29

1.94

1.5

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

218

1.61

1.93

1.2

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

127

1.82

1.93

1.2

1.1

ng/l

2032.9

487.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.75

1.93

1.5

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

172

1.69

1.92

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

172

1.69

1.92

1.2

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

405

1.44

1.91

1.3

—

(4024509)

323

1.49

1.90

1.8

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

464

1.41

1.90

1.7

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.00

1.90

1.8

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

150

1211

1.25

1.87

2.6

2.3

g/l

1.5

0.9

0.84

115

1050

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

138

1106

1.26

1.84

2.2

2.1

g/l

38.2

37.6

0.58

105

966

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

198

1.62

1.83

1.3

u/ml

0.3

1.2

0.83

(21494434) Karyotype in Bone marrow

310

1.49

1.82

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.17

1.82

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

183

1.64

1.81

5.6

6.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.92

1.80

1.1

88.7

88.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

430

3825

1.14

1.78

2.7

umol/l

6.8

8.6

1.34

371

3328

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

430

3825

1.14

1.78

1.9

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

378

1.43

1.78

1.4

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

227

1923

1.19

1.77

1.1

1.2

iu/ml

229.2

143.9

0.61

698

(3012441) Differential panel - Pleural fluid

387

1.43

1.76

1.6

1.4

—

(3001556) Androgen free Index in Serum or Plasma

3.34

1.74

1.3

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

124

992

1.26

1.70

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

726

1.30

1.70

1.3

miu/ml

245.7

209.4

0.35

313

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

211

1.57

1.67

1.2

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1133

10650

1.09

1.67

3.3

u/l

30.9

37.0

2.26

1062

10062

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

1.68

1.66

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

134

1.72

1.65

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

134

1.72

1.65

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

1.72

1.65

1.9

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

228

1.54

1.64

1.5

pmol/l

95.0

196.3

0.33

(3052592) Norovirus Ag [Presence] in Stool

2.03

1.64

1.1

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

260

2245

1.17

1.64

2.0

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

236

2022

1.18

1.64

2.0

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

120

1.75

1.62

1.0

1.1

miu/ml

1858.3

1731.6

0.19

120

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

166

1.63

1.61

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

450

0.64

1.61

4.1

5.0

umol/l

344.0

356.8

0.17

387

(3021901) Oxygen saturation in Capillary blood

636

1.31

1.60

3.2

2.9

—

(3004451) EKG impression Narrative

182

1.60

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

231

1.52

1.56

1.9

2.1

20.7

13.4

0.75

(3025018) Bordetella pertussis Ab [Titer] in Serum

160

1.63

1.55

1.3

1.2

—

(40762814) Titanium [Mass/volume] in Blood

2.11

1.55

2.2

2.3

ug/l

2.7

4.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

675

1.30

1.54

6.2

5.3

iu/ml

1245.2

3020.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.93

1.54

1.4

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

109

871

1.26

1.54

1.1

1.2

titre

104.0

98.8

—

(4035726)

354

3147

1.14

1.51

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

324

1.42

1.51

1.2

1.4

e6/l

213332.9

103959.6

0.35

230

(46235355) HIV 1 and 2 tests - Meaningful Use set

506

4598

1.12

1.50

1.9

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

102

812

1.26

1.49

1.5

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

539

1.32

1.48

2.2

1.8

mmol/l

1.7

0.11

524

(40768806) Pleura Pathology biopsy report

393

1.38

1.48

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

733

1.28

1.48

2.7

2.8

umol/l

33.5

35.3

0.26

616

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.81

1.47

1.1

1.3

94.3

88.9

—

(3021788) Differential panel - Synovial fluid

620

1.30

1.45

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

594

1.30

1.44

1.2

1.4

mmol/l

65.9

62.7

0.30

475

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.13

1.44

5.4

3.8

—

(3050794) Legionella sp Ab [Presence] in Serum

2.73

1.43

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.79

1.42

5.0

5.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.82

1.41

1.7

1.9

ug/l

0.5

1.2

2.20

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

431

1.35

1.41

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

287

1.43

1.40

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

287

1.43

1.40

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

287

1.43

1.40

1.7

1.6

—

(4027681)

173

1.56

1.39

1.3

1.2

—

(3014891) Appearance of Pleural fluid

2.08

1.38

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.08

1.38

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

140

1166

1.21

1.37

1.8

—

(3000330) Specific gravity of Urine by Test strip

145

1727

0.83

1.37

3.6

3.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

198

1.52

1.37

1.0

1.1

nmol/l

1.8

8.8

—

(3024932) HLA-DR beta [Type]

1.80

1.37

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.94

1.36

1.8

1.5

—

(4281824)

358

0.64

1.34

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.15

1.33

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.78

1.33

1.9

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.50

1.30

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

108

1315

0.82

1.30

3.4

u/ml

115.1

4089.8

1.17

1122

(3000060) B lymphocytes [#/volume] in Blood

1.85

1.29

2.0

2.2

e6/l

117.5

155.1

—

(3000034) Microalbumin [Mass/volume] in Urine

301

1.40

1.29

3.6

3.2

mg/l

74.2

39.8

0.55

224

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

185

1.52

1.28

1.8

1.6

u/field

2.6

2.3

0.06

136

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

169

1.54

1.28

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

169

1.54

1.28

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

169

1.54

1.28

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

169

1.54

1.28

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.27

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

174

1491

1.17

1.26

1.1

1.0

—

(3024471) HLA-A [Type]

1.74

1.24

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.22

1.24

1.1

1.3

umol/24h

1.9

1.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

434

1.32

1.21

1.9

1.7

87.7

89.6

0.88

428

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.63

1.21

1.8

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

513

1.29

1.21

1.1

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

674

1.25

1.20

1.8

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

138

1624

0.84

1.18

2.6

3.8

u/ml

28.8

62.2

4.09

129

1565

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

126

1058

1.20

1.17

1.6

1.7

mg/l

3.3

3.7

0.18

749

(3037756) Immunofixation for Serum or Plasma

749

1.23

1.16

1.4

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

2632

26891

0.94

1.16

20.1

18.4

13.7

0.35

2590

26308

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.00

1.16

9.2

14.2

mmol/l

4.8

5.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

1.15

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

386

1.33

1.15

1.1

1.0

u/ml

3.9

2.5

0.43

168

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.00

1.12

4.0

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

575

1.26

1.09

1.3

1.2

u/l

40.4

43.3

0.08

499

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

117

984

1.19

1.09

2.5

g/l

3.4

3.6

1.34

108

936

(3036525) Urea [Moles/time] in 24 hour Urine

2.38

1.09

4.6

2.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

487

1.28

1.08

1.8

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

821

1.21

1.07

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.76

1.06

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

180

0.55

1.06

1.0

1.1

—

(44806118)

365

1.32

1.06

1.6

1.4

—

(44790049)

365

1.32

1.06

1.6

1.4

—

(44790047)

365

1.32

1.06

1.6

1.4

—

(44790048)

365

1.32

1.06

1.6

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

164

1423

1.16

1.06

5.0

5.4

1.8

1.6

0.75

157

1321

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

145

1.52

1.05

1.2

u/ml

2.0

6.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

129

1.55

1.05

1.7

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

245

2187

1.13

1.05

8.5

7.0

mmol/l

24.6

0.01

234

2023

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

288

3189

0.90

1.05

2.9

2.4

u/l

38.9

53.1

0.44

249

2731

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

195

1.44

1.04

1.7

1.6

u/l

5.8

7.3

0.58

168

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

280

1.36

1.03

1.8

1.9

u/field

1.7

2.0

0.11

113

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.27

1.03

1.8

2.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.96

1.03

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

643

1.23

1.03

1.7

1.6

—

(3044889) 12 lead EKG panel

2407

23519

1.06

1.03

4.3

3.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

334

0.69

1.01

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

1.00

1.0

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

139

1.51

1.00

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

251

2253

1.12

0.99

1.3

—

(3045142) Bone marrow Pathology biopsy report

405

1.29

0.99

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

315

2865

1.11

0.98

5.9

3.9

mmol/l

1.2

0.21

288

2500

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

300

1.34

0.98

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

332

0.69

0.98

1.3

1.4

—

(3025315) Body weight

2.18

0.98

3.2

4.2

—

(3020891) Body temperature

157

1368

1.15

0.98

5.5

4.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

310

1.33

0.96

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

247

0.65

0.95

1.1

1.0

ng/l

549.6

715.5

—

160

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

404

3727

1.09

0.95

3.7

4.1

ug/l

6.2

23.1

4.39

324

3047

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

233

1.38

0.95

2.0

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

341

0.70

0.95

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

972

9273

1.06

0.94

3.7

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

102

862

1.19

0.93

1.2

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.62

0.93

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.22

0.93

1.7

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

312

1.32

0.93

2.2

2.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.73

0.92

1.1

1.5

ng/l

107.9

148.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.73

0.92

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

392

1.28

0.92

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.14

0.91

3.0

4.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

184

1.42

0.91

1.6

1.3

nmol/l

1.4

1.2

0.33

142

(21494814) CD8 cells/100 lymphocytes in Specimen

126

1.51

0.91

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

176

1.42

0.90

1.1

u/l

1.0

1.1

0.57

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

402

1.27

0.90

1.4

1.3

pmol/l

243.8

272.8

0.49

313

(3025130) Human papilloma virus identified in Specimen

335

0.71

0.87

1.1

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

351

1.29

0.87

1.3

1.2

u/l

51.1

59.8

0.66

239

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

178

1.41

0.86

1.0

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

769

1.19

0.85

3.2

3.5

u/ml

170.2

716.8

0.94

712

(1761482) Bacteria [#/volume] in Urine by Culture

845

0.83

0.85

5.3

4.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

397

1.26

0.85

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.56

0.84

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.78

0.84

1.0

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1081

10386

1.06

0.82

3.8

3.3

e6/l

49.9

79.7

0.75

850

7994

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.74

0.82

2.6

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

159

1408

1.13

0.82

5.5

0.9

0.68

152

1312

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

856

1.17

0.82

2.5

2.4

ug/min

147.1

110.7

0.34

534

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

453

1.24

0.82

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

337

1.28

0.81

1.8

1.4

iu/ml

20.3

26.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.55

0.81

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.70

0.80

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

198

1.37

0.80

2.0

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

250

1.32

0.80

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

164

1.40

0.79

3.7

4.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

188

0.64

0.79

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

114

1.49

0.79

1.2

1.3

mmol/l

4.3

3.3

0.62

101

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

175

1954

0.89

0.79

10.7

9.3

mmol/l

24.3

0.03

165

1822

(3030467) Casts [#/volume] in Urine by Automated count

994

9544

1.06

0.78

3.7

3.2

e6/l

0.4

0.5

0.76

762

7202

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

260

1.31

0.77

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.77

0.76

1.5

2.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

200

1.35

0.76

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

200

1.35

0.76

2.1

1.5

—

(4268621)

332

1.27

0.76

2.2

2.3

—

(3000012) Reticulocyte production index

183

1.37

0.75

1.8

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

395

1.24

0.75

1.1

1.0

u/ml

6.1

4.4

0.21

192

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

327

3528

0.92

0.75

1.5

1.8

1.4

1.5

2.22

283

3062

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

201

1.35

0.74

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

525

0.80

0.74

1.1

iu/ml

31.0

80.7

—

119

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

521

5515

0.94

0.72

3.4

3.0

e6/l

2.6

2.4

0.18

283

2997

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

144

1281

1.13

0.72

3.5

3.0

u/ml

0.3

0.43

729

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.62

0.71

2.5

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.58

0.71

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.58

0.71

1.4

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

318

1.26

0.70

1.6

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

170

0.65

0.70

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

151

1350

1.12

0.70

1.5

1.7

—

(3044941) Cell count panel - Synovial fluid

565

0.81

0.70

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

186

1.35

0.70

1.8

2.6

37.3

39.2

—

(3018095) Leukocytes [#/volume] in Urine

1234

11948

1.05

0.69

4.3

3.7

e6/l

81.5

110.6

1.12

909

8542

(3018418) pH of Serum or Plasma

1053

10157

1.05

0.69

5.3

4.1

7.4

0.47

251

1941

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.60

0.68

7.0

3.1

u/l

28.8

45.6

—

(21494755) Public health laboratory ask at order entry panel

220

2401

0.91

0.67

1.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.63

0.66

1.3

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

567

1.18

0.66

2.5

1.8

—

(3008295) Osmolality of Serum or Plasma

348

1.24

0.66

1.4

1.3

mosm/kgh2o

282.2

278.6

0.53

270

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

260

0.73

0.66

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

128

1.41

0.65

1.1

1.2

—

(4034850)

1022

0.87

0.65

11.7

9.7

—

(3051611) Lipemic interference index of Serum or Plasma

340

1.24

0.65

4.6

3.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

486

1.20

0.64

1.3

—

(3019150) Specific gravity of Urine by Refractometry

715

6844

1.05

0.64

4.5

4.1

kg/l

1.0

0.29

117

1057

(3003434) Protein [Mass/volume] in Pleural fluid

505

1.19

0.64

1.5

g/l

33.1

32.3

0.16

454

(3025549) Creatine [Moles/time] in 24 hour Urine

1.73

0.64

2.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.73

0.64

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.73

0.64

1.2

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.73

0.64

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

189

0.69

0.63

2.2

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

462

4368

1.07

0.63

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

560

5884

0.94

0.63

3.1

2.8

e6/l

1.0

1.1

0.42

317

3349

(3006922) Hepatitis E virus Ab [Presence] in Serum

216

1.30

0.63

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

387

1.22

0.63

1.3

mmol/l

8.0

7.3

0.83

283

(3024263) Appearance of Synovial fluid

200

0.70

0.62

1.4

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

0.59

0.62

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.60

0.0

1.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

21.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

8.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.60

0.0

1.1

—

37.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.57

0.60

1.0

1.1

mg/g

8.8

9.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.50

0.59

2.7

2.6

—

67.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

186

0.70

0.59

1.7

2.1

ug/min

194.0

285.8

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.59

0.0

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

114

1.41

0.58

1.1

1.4

iu/ml

—

1308838.9

—

(3016038) Potassium [Moles/volume] in Urine

219

1.28

0.58

1.0

1.1

mmol/l

32.5

33.6

0.12

188

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.72

0.57

1.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

707

1.15

0.57

1.6

1.3

e6/l

54.0

26.6

0.30

540

(3000764) Benzodiazepines [Presence] in Urine

726

1.15

0.57

2.2

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

708

1.15

0.56

1.7

1.4

e6/l

3138.8

1332.7

0.37

572

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.67

0.56

5.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.67

0.56

2.5

3.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

211

1949

1.09

0.56

1.7

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

429

0.81

0.56

2.3

2.4

mmol/l

106.0

105.2

0.28

423

(3041354) Potassium [Moles/volume] in Venous blood

429

0.81

0.56

2.3

2.4

mmol/l

4.2

4.1

0.70

423

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

703

6758

1.05

0.55

4.1

3.7

ng/l

261.5

543.6

1.08

542

5449

(3033705) Calcium.ionized [Moles/volume] in Venous blood

417

0.81

0.55

2.3

2.5

—

(3027008) Opiates [Presence] in Urine

730

1.14

0.54

2.2

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

267

1.24

0.53

1.8

1.6

—

(4133840)

1.49

0.53

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.54

0.53

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

675

1.14

0.53

2.3

2.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.43

0.53

3.3

2.9

mg/l

9.0

7.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

101

902

1.12

0.52

1.2

1.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

177

1629

1.09

0.52

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

555

1.16

0.51

1.4

u/ml

110.4

119.4

0.30

103

(3023430) Cat dander IgE Ab [Units/volume] in Serum

278

1.22

0.51

1.0

1.1

u/ml

11.0

3.6

0.78

117

(3028308) Erythrocytes [#/volume] in Pleural fluid

407

1.18

0.50

1.6

1.4

e6/l

94733.0

58880.1

0.23

241

(3028300) Cannabinoids [Presence] in Urine

735

1.13

0.50

2.2

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

445

1.17

0.49

1.1

g/l

1.5

0.21

398

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

180

1.28

0.49

1.1

1.2

ratio

1.0

—

(3022621) pH of Urine by Test strip

234

2185

1.08

0.49

2.9

3.0

—

(3028433) Virus identified in Specimen by Culture

110

1.37

0.48

1.1

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

110

0.64

0.48

1.4

1.5

15.4

21.2

—

101

(40768441) Liver Pathology biopsy report

235

1.24

0.48

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

308

1.20

0.48

1.6

1.5

20.3

30.8

1.46

190

(44813793)

190

1.26

0.48

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.49

0.47

1.9

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

354

0.82

0.47

1.4

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

210

1959

1.08

0.46

11.0

9.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

173

1.27

0.46

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

210

0.76

0.46

3.3

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.38

0.46

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

449

1.16

0.45

1.2

1.1

u/ml

1.4

1.6

0.08

182

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

487

1.15

0.45

1.2

u/ml

3.5

4.0

0.23

206

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

111

1009

1.10

0.44

2.5

2.2

g/l

0.0

0.39

920

(3004716) Salmonella sp identified in Stool by Organism specific culture

133

1447

0.92

0.44

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

139

1509

0.92

0.43

3.7

4.0

52.2

48.6

0.93

139

1491

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

330

1.18

0.43

1.1

—

(3016502) Oxygen saturation in Arterial blood

385

3672

1.05

0.43

8.5

7.7

95.5

95.6

0.15

372

3532

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

630

1.13

0.43

1.5

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

104

1.35

0.43

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

303

1.19

0.43

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

203

1.23

0.42

6.0

3.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.38

0.41

3.0

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.52

0.41

1.4

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.2

—

3.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.41

0.0

1.6

—

23.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

326

0.83

0.41

1.6

1.7

—

(3020491) Glucose [Moles/volume] in Blood

250

1.20

0.40

1.7

2.5

mmol/l

6.9

6.7

0.13

166

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

132

1.29

0.40

1.1

2.5

umol/l

15.0

145.7

—

(4211845)

177

1.24

0.40

6.7

3.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.40

0.0

4.8

—

22.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

616

1.12

0.39

1.8

1.5

—

(3045788) Cell count panel - Pleural fluid

357

0.84

0.39

2.0

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

381

1.16

0.39

1.1

1.0

u/ml

1.5

1.3

0.07

155

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

106

1.32

0.39

1.4

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

791

0.90

0.39

2.3

2.1

—

(3023410) Appearance of Cerebral spinal fluid

316

1.17

0.38

1.7

1.5

—

(40768446) Kidney Pathology biopsy report

124

1.29

0.38

1.6

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

589

1.12

0.38

1.2

—

(3006462) Nitrate [Presence] in Urine

160

1.25

0.38

7.3

3.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

307

1.17

0.38

1.0

u/ml

8.8

2.6

0.84

123

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

151

1.26

0.38

2.3

2.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.38

1.0

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

321

3062

1.05

0.38

3.6

2.8

ng/l

193.2

204.3

0.20

302

2785

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.35

0.37

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.31

0.37

1.1

—

(3000991) Gas panel - Venous blood

279

2932

0.95

0.37

10.1

8.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

246

0.81

0.37

1.2

1.3

mmol/l

10.8

12.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

134

1.27

0.36

12.7

5.3

mg/l

53.6

65.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

244

1.19

0.36

1.2

titre

—

(3011648) Oxygen content in Venous blood

272

1.18

0.36

1.7

2.0

11.0

11.1

0.02

272

(3006653) Thiamine [Moles/volume] in Blood

171

1.23

0.35

1.1

1.3

nmol/l

150.8

138.3

0.52

171

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.43

0.35

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

135

1.26

0.35

1.5

1.6

nmol/l

1.9

8.4

1.21

116

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

116

1073

1.08

0.35

2.4

2.2

g/l

0.0

0.73

102

981

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.37

0.34

1.2

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

259

2466

1.05

0.34

1.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.33

0.33

1.0

—

(4094501)

101

931

1.09

0.33

1.1

—

(3015183) Erythrocyte sedimentation rate

136

1.25

0.33

1.1

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

539

1.11

0.33

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.70

0.33

1.0

1.1

—

(3016750) Collection duration of Urine

210

1.19

0.32

2.6

2.0

min

496.8

494.6

0.03

154

(3000492) Spirometry study

316

3031

1.05

0.32

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

143

0.77

0.32

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

103

954

1.08

0.31

2.3

2.4

186.6

197.5

0.65

903

(40758292) HTLV I+II Ab panel - Serum

1.35

0.31

1.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

742

7604

0.97

0.31

4.1

3.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

352

1.14

0.31

2.9

3.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.30

0.30

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

335

1.14

0.29

1.1

1.2

—

(3024928) Oxygen saturation in Venous blood

746

1.09

0.29

3.5

2.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

107

998

1.07

0.28

2.6

2.2

g/l

0.0

0.00

919

(3020191) Ethanol [Moles/volume] in Serum or Plasma

251

1.16

0.28

2.1

1.4

promille

0.9

1.2

0.65

194

(3021447) Carbon dioxide [Partial pressure] in Venous blood

308

3197

0.96

0.27

4.5

3.8

kpa

5.9

5.8

0.02

300

3100

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

233

1.16

0.27

2.0

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

740

0.92

0.27

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

740

0.92

0.27

1.3

—

(3023419) Bacteria identified in Sputum by Culture

442

1.11

0.27

2.5

2.4

—

(3011288) Drugs identified in Urine by Screen method

471

1.11

0.26

2.8

2.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.19

0.26

1.3

3.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

206

1.17

0.26

1.7

1.6

u/l

1.7

5.7

—

102

(3043410) Blood group antigens tested for on Red Blood Cells

1.28

0.26

1.5

—

(3035880) pH of Pleural fluid

203

0.84

0.25

1.2

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

650

6355

1.03

0.25

3.0

3.2

mmol/l

2.5

0.78

575

5559

(3004775) Volume in Urine collected for unspecified duration

283

1.13

0.24

2.6

2.2

680.6

656.6

0.12

186

(4306422)

486

0.90

0.24

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.28

0.24

1.2

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

255

1.14

0.24

1.1

1.0

mg/l

300.2

289.8

0.27

228

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

552

1.09

0.23

1.3

1.2

u/ml

265.5

279.7

0.15

341

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

1.23

0.23

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

109

1028

1.06

0.23

1.3

1.4

iu/l

26.5

31.4

0.97

878

(3017704) Immunofixation for Urine

190

1.16

0.23

1.0

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.24

0.23

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

232

0.86

0.22

1.3

1.7

—

(3027944) Amphetamines [Presence] in Urine

718

1.07

0.22

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.76

0.22

1.3

1.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.25

0.22

1.8

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.25

0.22

1.8

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.25

0.22

1.8

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

251

2600

0.96

0.22

3.3

3.1

kpa

4.9

4.6

1.21

244

2513

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

229

1.14

0.21

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

449

1.09

0.21

1.6

1.4

e6/l

2604.3

2014.4

0.44

328

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

1.11

0.21

1.1

1.0

u/ml

7.2

2.5

0.47

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

936

0.94

0.21

1.2

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

1.6

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

249.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.8

—

2025.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

769

1.07

0.21

1.7

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

101

0.79

0.21

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

105

0.76

0.21

3.1

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.25

0.20

1.4

1.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.5

—

12.4

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

347

3376

1.03

0.20

9.1

8.1

g/l

122.1

121.0

0.39

338

3241

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

108

1.20

0.20

2.0

1.3

umol/l

4.3

4.5

0.13

100

(3033799) Differential panel - Peritoneal fluid

114

0.79

0.20

2.8

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

118

1.19

0.19

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

530

1.08

0.19

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

172

1655

1.04

0.19

5.2

4.0

mmol/l

24.7

24.2

1.33

151

1497

(3041806) Other cells [#/volume] in Blood by Manual count

1.13

0.18

2.7

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

251

1.12

0.18

1.0

u/ml

5.4

0.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

261

1.11

0.18

1.1

titre

104.0

112.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

261

1.11

0.18

1.1

—

131.4

—

(3002032) Base excess in Venous blood by calculation

311

3192

0.97

0.17

4.5

3.8

mmol/l

1.9

2.0

0.08

257

2609

(3025577) Chromium [Mass/volume] in Blood

233

1.12

0.17

1.9

2.1

ug/l

1.2

2.0

2.44

198

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.21

0.17

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.21

0.17

7.5

7.8

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

247

0.89

0.17

1.3

1.5

g/l

0.9

0.07

247

(3008536) Aspergillus sp Ab [Presence] in Serum

0.72

0.17

2.4

2.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.71

0.16

1.8

2.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.11

0.16

1.1

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

477

1.07

0.15

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.75

0.15

1.3

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.15

0.15

1.8

2.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.15

0.15

1.2

1.0

—

(3003396) Base excess in Arterial blood by calculation

418

4099

1.02

0.15

8.2

7.3

mmol/l

1.3

1.1

0.44

332

3189

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.13

0.15

2.2

1.4

ug/l

7.0

9.0

—

(3019977) pH of Arterial blood

207

1.11

0.15

5.7

2.6

7.4

0.25

(40768800) Prostate Pathology biopsy report

818

0.95

0.14

1.1

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

336

0.92

0.13

4.7

3.8

u/ml

76.3

46.0

0.24

336

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.17

0.13

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

238

1.09

0.13

2.5

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

273

0.92

0.13

1.4

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

687

1.05

0.12

3.6

1.9

nmol/l

1.0

0.9

0.23

581

(44816559) Phosphatidylethanol [Mass/volume] in Blood

560

1.05

0.12

1.4

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

385

1.07

0.12

1.3

2.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

220

0.91

0.12

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

752

0.96

0.11

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

887

1.04

0.11

1.2

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

449

4431

1.02

0.10

8.0

7.0

mmol/l

104.8

104.4

1.10

443

4329

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.13

0.09

7.4

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.13

0.09

7.4

2.6

—

(3000285) Sodium [Moles/volume] in Blood

1.09

0.09

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

566

1.04

0.09

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.07

0.08

1.0

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

211

2073

1.02

0.08

3.6

3.2

g/l

127.5

128.7

0.31

204

2017

(3014111) Lactate [Moles/volume] in Serum or Plasma

313

3087

1.02

0.08

7.6

7.1

mmol/l

1.3

1.4

0.47

305

2975

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

117

1.11

0.08

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

401

1.05

0.08

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

816

1.03

0.07

1.2

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

416

4115

1.01

0.07

8.1

7.3

kpa

12.3

0.01

403

3912

(42529406) Shigella sp [Presence] in Stool by Culture

945

0.97

0.07

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

323

1.05

0.07

1.3

—

(40757373) Influenza virus identified in Isolate

1.07

0.07

2.6

1.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.07

0.07

1.4

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

112

0.89

0.07

1.3

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

112

0.89

0.07

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

416

4117

1.01

0.07

8.1

7.3

kpa

5.0

5.1

2.25

401

3912

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

245

0.94

0.07

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.87

0.06

1.4

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

403

1.04

0.06

1.4

—

(1002224) Polysomnography panel

118

1205

0.98

0.06

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

244

0.94

0.06

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

244

0.94

0.06

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

404

1.04

0.06

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

404

1.04

0.06

1.4

—

(3036489) Thrombin time

130

1277

1.02

0.06

1.9

2.0

21.3

21.5

0.18

108

1120

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

0.93

0.05

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

405

1.04

0.05

1.4

—

(3020650) Glucose [Presence] in Urine

1.11

0.05

1.4

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

712

1.03

0.05

3.5

mg/l

29.8

27.5

0.19

464

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

149

1.07

0.05

2.9

2.6

—

(44806420)

100

1.10

0.05

2.8

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

939

0.98

0.05

1.2

1.1

—

(3034426) Prothrombin time (PT)

110

0.91

0.05

1.0

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

238

1.05

0.05

1.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

535

0.97

0.05

1.1

—

(3047189) Immunofixation for 24 hour Urine

189

1.06

0.04

1.2

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

104

1023

1.02

0.04

4.4

3.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

180

0.94

0.04

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

111

1.08

0.04

2.2

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

766

1.02

0.03

1.6

1.8

iu/l

3.6

4.7

0.80

264

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

498

1.02

0.03

1.2

u/ml

2.4

3.4

0.36

162

(40758558) Short blood count panel - Blood

847

8499

1.00

0.03

7.0

6.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

157

1586

0.99

0.03

3.6

2.7

1.2

0.08

157

1574

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

171

1.05

0.03

1.1

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

886

8839

1.00

0.02

4.2

4.0

87.2

88.5

0.80

869

8635

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

182

1.04

0.02

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

182

1.04

0.02

1.5

1.6

—

(3021589) Normoblasts [#/volume] in Blood

1463

14652

1.00

0.02

12.3

9.7

e9/l

0.0

0.75

1253

11956

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

489

0.98

0.02

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.08

0.02

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

1.07

0.02

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

412

1.02

0.01

1.1

—

(3017569) Oxygen content in Arterial blood

183

1.04

0.01

2.5

2.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

193

1.04

0.01

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

889

8904

1.00

0.01

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.06

0.01

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

114

1.05

0.00

1.3

1.4

77.6

55.2

2.97

(3036603) Volume of Urine

234

1.03

0.00

1.3

1.5

2498.1

1893.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

246

0.98

0.00

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

246

0.98

0.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

246

0.98

0.00

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

436

0.99

0.00

1.3

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

162

1626

1.00

0.00

3.4

3.5

mmol/l

24.9

25.4

0.88

157

1581

(3028707) Methadone [Presence] in Urine by Screen method

328

1.01

0.00

3.8

2.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

165

1.03

0.00

4.4

2.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

412

1.00

0.00

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

154

1545

1.00

0.00

3.1

2.6

0.7

0.04

149

1482

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

121

0.99

0.00

4.1

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

286

1.01

0.00

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

204

0.98

0.00

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.03

0.00

2.5

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3002619) Bacteria identified in Specimen by Culture

1.01

0.00

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.02

0.00

10.2

4.8

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.01

0.00

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.01

0.00

7.6

8.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

1.1

—

4.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

2268.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.92

0.00

1.7

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.94

0.00

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

5.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.96

0.00

1.6

1.1

—

(4198724)

1.01

0.00

1.6

1.7

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_IDIOP and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_IDIOP	0.9 [0.82, 0.99]	0.036
Birth year	0.997 [0.99, 1.01]	0.47

During the follow-up period (1.1.1998 — 31.12.2019), 1342 out of 9703 females with H8_HL_IDIOP died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_IDIOP	0.86 [0.78, 0.95]	0.003
Birth year	0.988 [0.98, 1.0]	0.016

During the follow-up period (1.1.1998 — 31.12.2019), 1633 out of 9777 males with H8_HL_IDIOP died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_IDIOP.

N-year risk	Females	Males
1	0.085%	0.141%
5	0.603%	0.918%
10	1.326%	2.653%
15	2.72%	4.967%
20	4.618%	8.504%

Relationships between endpoints

↥

Index endpoint: H8_HL_IDIOP – Sudden idiopathic hearing loss

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sudden idiopathic hearing loss

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints